Dangers of a nationalist vaccine

In the time of COVID-19, the Indian government has shown an embarrassing readiness to cut corners by seeking to push through a vaccination by …

Bharat Biotech COVID-19 vaccine gets govt panel nod for emergency use: Experts express concern

Recommendation to drug controller for emergency approval to India’s indigenous product against COVID-19

Delaying the second COVID-19 vaccine dose: A medical expert answers key questions

The uncertainty is around how long the protective effect of the first dose will last without a second shot

Centre signs deal with Serum Institute for 11 million COVID-19 vaccine doses: Sources

Talks on with Bharat Biotech; no official statement from government or manufacturers yet

COVID-19 immunity: how long does it last?

In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic 

India starts COVID-19 vaccination drive; Modi calls doubts over vaccine ‘propaganda’

Prime Minsiter urges people to not drop caution even after being vaccinated 

Covid-19 vaccination drive rolled out in Punjab and Himachal Pradesh, skepticism lingers

Some ASHA workers refused to get the jab on Saturday 

Kerala starts COVID-19 vaccination; doubts, hesitancy, ignorance linger

The state will be holding back half of the vaccine stock it has received due to a shortfall

Bhopal Covaxin trial participants allege side-effects, irregularities

Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there

Hesitancy challenges Tamil Nadu’s COVID-19 vaccination drive

Only 6,156 people all over the state had voluntarily got vaccinated January 16 and 17, 2021

Wary healthcare workers in Assam inoculated with COVID-19 vaccines

Beneficiaries January 16, especially expressed wariness about Covaxin, compared to Covishield

COVID-19 vaccination begins in Bihar; 30,000 health workers to be inoculated today

The vaccination will be staggered over three phases with health and frontline workers and people of 50 to get the shot first

COVID-19 vaccine hesitancy worries Centre, appeals beneficiaries to shun it

‘Covaxin recipients being followed-up with phone calls, Covishield’s have to report adverse events on their own’

Vaccine production in South Africa: how an industry in its infancy can be developed

Only if investment is increased, sustained, and backed by political commitment, will the country have sufficient vaccine production capacity

Vaccine Watch: 5 dead in Serum Institute fire; UAE okays Sputnik

PM likely to be vaccinated in March or April, doctor in Shivamogga dies two days after receiving jab and Israel denies vaccine efficacy fears

Norway deaths, social media rumours: Why healthcare workers in Bihar are staying away from vaccines

Nearly 40% healthcare workers scheduled for first 3 days give the jab a miss

COVID-19 vaccine hesitancy among healthcare workers in Andhra Pradesh

A number of workers, including doctors, refused to take the jab January 16, the day of the vaccination drive

Telangana COVID-19 vaccine recipient dies; govt says no link to immunisation

All three deaths following immunisation in India attributed to heart attack with no disease history

Gujarat recipients gung-ho on COVID-19 vaccine

The state will vaccinate about 440,000 healthcare workers and 355,000 frontline workers in the first round

Coronavirus variants: why being more transmissible rather than more deadly isn’t good news

At the heart of this assertion lies an old foe that has plagued us right from the start of this pandemic: exponential growth

Hesitancy, logistical challenges behind low turnout at vaccination camps in West Bengal

State is vaccinating health workers beyond the online list generated by Co-WIN app to attain target

Covaxin effective against UK Strain: What does this mean in absence of efficacy data?

Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts

Lateral Thoughts: Waiting for bad news

Adverse reactions are part and parcel of vaccination. We can know about safety of COVID-19 vaccines being used in India only after people receive …

Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy

'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'    

Resurgence of COVID-19 cases serious concern: Centre

‘Clinical trial mode’ condition of Covaxin manufactured by Bharat Biotech International taken off; Covaxin granted licence similar to …